Top Stories World National Business Technology Entertainment Sports Science Health

Ebola cases top 4,000 in DRC as WHO urges Ervebo vaccine trial

2 sources·Updated August 7, 2026

Covered by 2 sources

Bloomberg Politics·23h ago
Congo Ebola Outbreak: Merck Ervebo Vaccine, Gilead Remdesivir Eyed for Wider Use
Merck & Co.’s Ebola vaccine and an antiviral drug from Gilead Sciences Inc. are set for wider use in eastern Democratic Republic of Congo to blunt the fastest-growing Ebola outbreak on record.
Read at Bloomberg Politics →

Read it better in the app

Every story, every source, in one clean feed — with breaking-news alerts, offline reading and dark mode. Free.

Download on theApp StoreAndroid — coming soon

Get the full experience — free on mobileGet the app